A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2026 Update for Clinicians and Scientists
Pathogens and Immunity · 31.05.2026 · 11 (1) · 154-190
DOI: 10.20411/pai.v11i1.970 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens and Immunity, online erschienen am 31.05.2026. Verfasst von Simone Tunesi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, AOU SS Antonio e Biagio e C. Arrigo, Alessandria, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Tuberculosis (TB) remains a major cause of morbidity and mortality worldwide, while infections from non-tuberculous mycobacteria (NTM) represent a growing public health threat. In its 20th year of activity, the Tuberculosis Network European Trials group (TBnet; www.tbnet.eu) is one of the leading research networks in Europe. In this review, we summarize the main advances in TB and NTM that occurred in 2025.
Methods
We conducted a non-systematic review of articles published in 2025, with a strong emphasis on research with current or potential impact on clinical practice. We also selected the most impactful papers regarding the management of adult TB, pediatric TB, and NTM infections.
Results
Members of the TBnet Steering Committee summarize the main advances in their areas of interest, including epidemiology, pathogenesis, prevention, diagnosis, treatment, pediatric TB, and NTM infections. We also include a summary of future research priorities.
Conclusions
The year 2025 presented many exciting advancements in almost all fields of mycobacterial science. This article provides an expert-based, clinically orientated summary of the main new findings in the TB and NTM fields and aims to provide an updated overview of the state of the art in those areas.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases Unit, AOU SS Antonio e Biagio e C. Arrigo, Alessandria, Italy.
- Department of Public Health and Pediatric Sciences, University of Turin, Italy.
- Homerton University Hospital, London, United Kingdom.
- Queen Mary University of London, London, United Kingdom.
- London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Department of Pulmonology, Allergology and Clinical Immunology, Inselspital Bern, Bern University Hospital, Bern, Switzerland.
Zitieren
APA
Tunesi, S., Bothamley, G., Günther, G., Kherabi, Y., Kuksa, L., Lange, B., Lange, C., Lorent, N., Saluzzo, F., Sester, M., Iversen, X. E. S., Tebruegge, M., Tweed, C., Vasiliu, A., Guglielmetti, L., & Tuberculosis Network European Trials group (TBnet) (2026). A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2026 Update for Clinicians and Scientists. Pathogens and Immunity, 11(1), 154-190. https://doi.org/10.20411/pai.v11i1.970
Vancouver
Tunesi S, Bothamley G, Günther G, Kherabi Y, Kuksa L, Lange B, et al. A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2026 Update for Clinicians and Scientists. Pathogens and Immunity. 2026;11(1):154-190. doi:10.20411/pai.v11i1.970
BibTeX
@article{Tunesi2026,
author = {Tunesi, Simone and Bothamley, Graham and Günther, Gunar and Kherabi, Yousra and Kuksa, Liga and Lange, Berit and Lange, Christoph and Lorent, Natalie and Saluzzo, Francesca and Sester, Martina and Iversen, Xenia Emilie Sinding and Tebruegge, Marc and Tweed, Conor and Vasiliu, Anca and Guglielmetti, Lorenzo and Tuberculosis Network European Trials group (TBnet), Tuberculosis Network European Trials group (TBnet)},
title = {A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2026 Update for Clinicians and Scientists},
journal = {Pathogens and Immunity},
year = {2026},
volume = {11},
number = {1},
pages = {154--190},
doi = {10.20411/pai.v11i1.970}
}
EUVIMED